169 related articles for article (PubMed ID: 37902006)
21. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].
Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the cachexia index in patients with stage I-III colorectal cancer who underwent laparoscopic surgery.
Kamada T; Haruki K; Nakashima K; Takahashi J; Nakaseko Y; Suzuki N; Ohdaira H; Eto K; Ikegami T; Suzuki Y
Surg Today; 2023 Sep; 53(9):1064-1072. PubMed ID: 36725756
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive comparison of the prognostic value of systemic inflammation biomarkers for cancer cachexia: a multicenter prospective study.
Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Yang M; Tang M; Song CH; Deng L; Shi H
Inflamm Res; 2022 Nov; 71(10-11):1305-1313. PubMed ID: 35962796
[TBL] [Abstract][Full Text] [Related]
24. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.
Meng Y; Long C; Huang X; Huang L; Liao L; Tang W; Liu J
Bioengineered; 2021 Dec; 12(1):5138-5148. PubMed ID: 34436973
[TBL] [Abstract][Full Text] [Related]
26. Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer.
Hwang EC; Hwang IS; Yu HS; Kim SO; Jung SI; Hwang JE; Kang TW; Kwon DD; Park K; Ryu SB
Jpn J Clin Oncol; 2012 Oct; 42(10):955-60. PubMed ID: 22844127
[TBL] [Abstract][Full Text] [Related]
27. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.
Utsumi M; Inagaki M; Kitada K; Tokunaga N; Kondo M; Yunoki K; Sakurai Y; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
Anticancer Res; 2022 Oct; 42(10):4963-4971. PubMed ID: 36191973
[TBL] [Abstract][Full Text] [Related]
29. Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer.
Rocha BMM; Dolan RD; Paiva CE; McGovern J; Paiva BSR; Preto DD; McMillan DC; Maia YCP; Laird BJ
J Pain Symptom Manage; 2023 Apr; 65(4):348-357. PubMed ID: 36493981
[TBL] [Abstract][Full Text] [Related]
30. The impact of postoperative inflammation on recurrence in patients with colorectal cancer.
Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Konishi H; Komatsu S; Shiozaki A; Otsuji E
Int J Clin Oncol; 2020 Apr; 25(4):602-613. PubMed ID: 31758273
[TBL] [Abstract][Full Text] [Related]
31. Validity of the diagnostic criteria from the Asian Working Group for Cachexia in advanced cancer.
Sakaguchi T; Maeda K; Takeuchi T; Mizuno A; Kato R; Ishida Y; Ueshima J; Shimizu A; Amano K; Mori N
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):370-379. PubMed ID: 38115133
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
[TBL] [Abstract][Full Text] [Related]
33. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
[TBL] [Abstract][Full Text] [Related]
34. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
[TBL] [Abstract][Full Text] [Related]
35. The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.
Tominaga T; Nonaka T; Sumida Y; Hidaka S; Sawai T; Nagayasu T
PLoS One; 2016; 11(12):e0167967. PubMed ID: 27930703
[TBL] [Abstract][Full Text] [Related]
36. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
[TBL] [Abstract][Full Text] [Related]
37. Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer.
Ghanim B; Schweiger T; Jedamzik J; Glueck O; Glogner C; Lang G; Klepetko W; Hoetzenecker K
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):616-23. PubMed ID: 26242317
[TBL] [Abstract][Full Text] [Related]
38. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.
Leung EY; Scott HR; McMillan DC
J Thorac Oncol; 2012 Apr; 7(4):655-62. PubMed ID: 22425914
[TBL] [Abstract][Full Text] [Related]
40. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
Xie H; Ruan G; Wei L; Deng L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Yang M; Song C; Zhang X; Shi H
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):869-878. PubMed ID: 36852672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
